Hany Marei, Ph.D. is a full professor since 2005, and he worked as the Head of Cytology and Histology Department, Faculty of Veterinary Medicine, Mansoura University, Mansoura, Egypt (1996 - May 2015). From May 2015 he moved to Qatar where he works as a project manager for Biomedical Research Center (BRC) at Qatar University (QU). His research interest lies in the field of gene expression, pathway analysis, and genetic profiling of stem cells. He published more than 55 papers (PLOS, Genomics, Molecular Cancer, JCP, Oncotarget, Spinal Cord) on genetic profiling of adult human olfactory bulb neural stem cells (OBNSCs) and Glioblastoma Cancer stem cells. He also published many papers about the therapeutic potential of human olfactory bulb neural stem cells (OBNSC) for neurodegenerative and traumatic diseases including Alzheimer’s, Parkinson’s (PD) and spinal cord injury (SCI). He is specially interested in exploring the molecular mechanism underlying Alzheimer’s disease (AD), and identification of common and rare variants (SNPs) associated with AD. In 2016, he published a book chapter (with Bentham Science Publishers (eBook series “Frontiers in Clinical Drug Research-Alzheimer Disorder; Vol. 4” entitled “Recent perspective about the amyloid cascade hypothesis and stem cell-based therapy in the treatment of Alzheimer’s disease”. He also published a book entitled “Human Olfactory Bulb Neural Stem Cells for Cell-based Therapy of Traumatic and Neurodegenerative CNS Disorders, LAMBERST, 2016”. He served as a member for promotion of professor and associate professor at the Supreme Council of Universities, Egypt (2012-2015). He had defended more than 20 master and PhD thesis in Biomedical sciences, and reviewers for more than 100 papers in the field of Biomedical research. He published more than 50 papers in regional and international indexed journals. Recently, he had awarded a grant funded by the Gulf Corporation Countries (GCC) program about the “Use of patient-specific iPSC to study stroke in GCC and Qatar”. This grant aims to generate iPSCs from Qatari stroke patients, differentiate them into different cell types relevant to stroke such as endothelial cells, thrombocytes, neurons, and to use RNA seq (transcriptome) to identify dysregulated pathways between stroke patients and their mimics. His latest work entitled “Genetically unmatched human iPSC and ESC exhibit equivalent gene expression and neuronal differentiation potential” is currently under publication. In 2018, Marei has awarded a major project entitled “FCy Chimeric Receptor T cells and monoclonal antibodies for Glioblastoma multiform immunotherapy: In vitro and in vivo Studies”. His research efforts is now concentrating on understanding basic immunology and translational research including clinical trials for evaluating the effects of immunotherapy in vitro, in vivo and in patients with primary brain tumors. The main aim of his research goals is to promotes and supports collaborations across the basic, translational, and clinical research spectrum to develop novel therapeutics for individuals with primary central nervous system malignancies that will globally influence the field.